SEC Tracker
Get the app

GeoVax Labs GOVX

GeoVax Labs (GOVX) filed its Q3 2025 Form 10-Q, providing investors with an update on the company's financial performance and operational activities during the quarter. The filing highlights the company's progress on key development programs and financial position, which is crucial for investors to assess the short-term health and prospects of the business.

Form
10-Q
Filed
Importance
Notable

Open in the appGet the appView on EDGAR

Get an email when GeoVax Labs files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Earth Science Tech ETST public float $14M, Mar 31, 2026
  2. Edesa Biotech EDSA public float $14M, Mar 31, 2025, over 18 months old
  3. Synergy CHC SNYR public float $13M, Jun 30, 2025
  4. Cellectar Biosciences CLRB public float $13M, Jun 30, 2025
  5. X4 Pharmaceuticals XFOR public float $15M, Jun 30, 2025